Trial Profile
A Study of BR55 in Contrast Enhanced Ultrasound Imaging in Patients with Ovarian and Breast Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Apr 2018
Price :
$35
*
At a glance
- Drugs BR-55 (Primary)
- Indications Breast cancer; Ovarian cancer
- Focus Diagnostic use
- Sponsors Bracco
- 18 Apr 2018 New trial record